Home › Focal Segmental Glomerulosclerosis › Delaware
Focal Segmental Glomerulosclerosis clinical trials in Delaware
3 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in Delaware.
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Nemours/A.I. duPont Hospital for Children, Wilmington
Recruiting
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT02235857Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Nemours/Alfred I DuPont Hospital for Children, Wilmington
Recruiting
Up to age 75 · All sexes · Updated Aug 28, 2026 · NCT04065438Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Nemours Children's Hospital, Wilmington
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.